Effects of the Federal Trade Commission's Repeal of Non-Compete Agreements on the Pharma Industry
In an interview with Associate Editor Donald Tracy, MA, Ron Lanton III, Esq., Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the #pharma industry.
The interview can be viewed here.